Skip to content
The Policy VaultThe Policy Vault

Alecensa (alectinib capsules – Genentech) — Cigna

Large B-Cell Lymphoma

Initial criteria

  • Patient age ≥ 18 years
  • Patient has anaplastic lymphoma kinase (ALK)-positive disease
  • Patient has relapsed or refractory disease

Approval duration

1 year